AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney d...